|
1
|
Younes HM, Kadavil H, Ismail HM, Adib SA, Zamani S, Alany RG, Al-Kinani AA. Overview of Tissue Engineering and Drug Delivery Applications of Reactive Electrospinning and Crosslinking Techniques of Polymeric Nanofibers with Highlights on Their Biocompatibility Testing and Regulatory Aspects. Pharmaceutics 2023; 16:32. [PMID: 38258043 PMCID: PMC10818558 DOI: 10.3390/pharmaceutics16010032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2023] [Revised: 12/12/2023] [Accepted: 12/14/2023] [Indexed: 01/24/2024] Open
Abstract
Traditional electrospinning is a promising technique for fabricating nanofibers for tissue engineering and drug delivery applications. The method is highly efficient in producing nanofibers with morphology and porosity similar to the extracellular matrix. Nonetheless, and in many instances, the process has faced several limitations, including weak mechanical strength, large diameter distributions, and scaling-up difficulties of its fabricated electrospun nanofibers. The constraints of the polymer solution's intrinsic properties are primarily responsible for these limitations. Reactive electrospinning constitutes a novel and modified electrospinning techniques developed to overcome those challenges and improve the properties of the fabricated fibers intended for various biomedical applications. This review mainly addresses reactive electrospinning techniques, a relatively new approach for making in situ or post-crosslinked nanofibers. It provides an overview of and discusses the recent literature about chemical and photoreactive electrospinning, their various techniques, their biomedical applications, and FDA regulatory aspects related to their approval and marketing. Another aspect highlighted in this review is the use of crosslinking and reactive electrospinning techniques to enhance the fabricated nanofibers' physicochemical and mechanical properties and make them more biocompatible and tailored for advanced intelligent drug delivery and tissue engineering applications.
Collapse
Affiliation(s)
- Husam M. Younes
- Tissue Engineering & Nanopharmaceuticals Research Laboratory (TENRL), Office of Vice President for Research & Graduate Studies, Qatar University, Doha P.O. Box 2713, Qatar; (H.K.); (H.M.I.); (S.A.A.)
| | - Hana Kadavil
- Tissue Engineering & Nanopharmaceuticals Research Laboratory (TENRL), Office of Vice President for Research & Graduate Studies, Qatar University, Doha P.O. Box 2713, Qatar; (H.K.); (H.M.I.); (S.A.A.)
| | - Hesham M. Ismail
- Tissue Engineering & Nanopharmaceuticals Research Laboratory (TENRL), Office of Vice President for Research & Graduate Studies, Qatar University, Doha P.O. Box 2713, Qatar; (H.K.); (H.M.I.); (S.A.A.)
- Charles River Laboratories, Montreal, QC H9X 3R3, Canada
| | - Sandi Ali Adib
- Tissue Engineering & Nanopharmaceuticals Research Laboratory (TENRL), Office of Vice President for Research & Graduate Studies, Qatar University, Doha P.O. Box 2713, Qatar; (H.K.); (H.M.I.); (S.A.A.)
| | - Somayeh Zamani
- Tissue Engineering & Nanopharmaceuticals Research Laboratory (TENRL), Office of Vice President for Research & Graduate Studies, Qatar University, Doha P.O. Box 2713, Qatar; (H.K.); (H.M.I.); (S.A.A.)
- Materials Science & Engineering, Cornell University, Ithaca, NY 14853, USA
| | - Raid G. Alany
- School of Pharmacy, The University of Auckland, Auckland 1142, New Zealand; (R.G.A.); (A.A.A.-K.)
- Drug Discovery, Delivery and Patient Care (DDDPC) Theme, School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Kingston upon Thames, London KT2 7LB, UK
| | - Ali A. Al-Kinani
- School of Pharmacy, The University of Auckland, Auckland 1142, New Zealand; (R.G.A.); (A.A.A.-K.)
| |
Collapse
|